Mirum Pharma (NASDAQ: MIRM) officer lines up $4M share sale
Rhea-AI Filing Summary
Mirum Pharmaceuticals, Inc. (MIRM) reports that officer Jolanda Marie Howe has notified of a proposed sale of 40,000 common shares, to be sold for cash on 08/18/2026 through Morgan Stanley Smith Barney, with an aggregate market value of $4,000,000.00, following a stock option exercise. She also reported prior sales of 1,840, 2,721, and 2,594 shares of common stock in June, July, and August 2026, respectively.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 40,000 shares
Aggregate market value of planned sale: $4,000,000.00
Shares sold on 08/03/2026: 1,840 shares
+5 more
8 metrics
Planned shares to be sold
40,000 shares
Common stock sale planned for 08/18/2026
Aggregate market value of planned sale
$4,000,000.00
Value for 40,000 Mirum common shares to be sold
Shares sold on 08/03/2026
1,840 shares
Common stock sold by Jolanda Marie Howe
Proceeds on 08/03/2026 sale
$193,733.60
Sale of 1,840 Mirum common shares
Shares sold on 07/01/2026
2,721 shares
Common stock sold by Jolanda Marie Howe
Proceeds on 07/01/2026 sale
$326,520.00
Sale of 2,721 Mirum common shares
Shares sold on 06/17/2026
2,594 shares
Common stock sold by Jolanda Marie Howe
Proceeds on 06/17/2026 sale
$264,458.30
Sale of 2,594 Mirum common shares
Key Terms
Rule 144, Stock Option Exercise, aggregate market value, Securities To Be Sold
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"Common | 08/18/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC ... | 40000 | 4000000.00"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 08/18/2026"
FAQ
What does this Form 144 disclose about Mirum Pharmaceuticals, Inc. (MIRM)?
It discloses that officer Jolanda Marie Howe plans to sell 40,000 common shares of Mirum Pharmaceuticals, Inc. on 08/18/2026 following a stock option exercise, with an aggregate market value of $4,000,000.00.
What is the nature of the securities transaction reported for MIRM on 08/18/2026?
The transaction is described as a Stock Option Exercise for Mirum common stock. The resulting 40,000 shares are to be sold for cash on 08/18/2026 through Morgan Stanley Smith Barney.
AI-generated analysis. How Rhea-AI works. Not financial advice.